Literature DB >> 2914882

Hallervorden-Spatz disease in a psychiatric setting.

M A Morphy1, J A Feldman, G Kilburn.   

Abstract

Neurodegenerative disorders of sufficient severity to be lethal are also likely to generate psychiatric symptomatology. At times, behavioral changes may predate neurologic manifestations, whereas at other times disturbances in mental status and physical functioning may coexist. In either situation, accurate assessment and appropriate treatment may prove challenging. The case of Hallervorden-Spatz disease reported here illustrates this difficulty; the authors present it to highlight the general issues that often arise in this group of illnesses. In this patient, as well as in three of his relatives, initially subtle neurologic signs were preceded by and then intermingled with significant and sometimes severe symptoms of depression. The authors emphasize the importance of attending to the neurologic symptom picture and family history in order to more appropriately assess the psychiatric manifestations of the disorder. Knowledge of neurodegenerative illnesses, even those as admittedly rare as Hallervorden-Spatz disease, can facilitate accurate and prompt diagnostic assessment, guide treatment strategies (including avoidance of inappropriate interventions), and help to more realistically define outcome expectations.

Entities:  

Mesh:

Year:  1989        PMID: 2914882

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

Review 2.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

3.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

4.  A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia.

Authors:  Yogesh Pawar; Gurvinder Kalra; Sushma Sonavane; Nilesh Shah
Journal:  Indian J Psychiatry       Date:  2013-10       Impact factor: 1.759

5.  Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Authors:  Allison Gregory; Mitesh Lotia; Suh Young Jeong; Rachel Fox; Dolly Zhen; Lynn Sanford; Jeff Hamada; Amir Jahic; Christian Beetz; Alison Freed; Manju A Kurian; Thomas Cullup; Marlous C M van der Weijden; Vy Nguyen; Naly Setthavongsack; Daphne Garcia; Victoria Krajbich; Thao Pham; Randy Woltjer; Benjamin P George; Kelly Q Minks; Alexander R Paciorkowski; Penelope Hogarth; Joseph Jankovic; Susan J Hayflick
Journal:  Mol Genet Genomic Med       Date:  2019-05-13       Impact factor: 2.183

6.  Psychiatric disorder in two siblings with hallervorden-spatz disease.

Authors:  Young-Kyung Sunwoo; Jeong-Seop Lee; Won-Hyoung Kim; Yong-Bum Shin; Myung-Ji Lee; In-Hee Cho; Sun-Myeong Ock
Journal:  Psychiatry Investig       Date:  2009-08-03       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.